Cindy Baker, MD
Interventional Cardiology · Columbus, OHNPI 1467400911
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. GE HealthCare accounts for 63.4% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $190, 5.1 times the $37 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in OH, where the typical reported total is $4,547.
Across 7 payments — averaging $37.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GE HealthCare$165
- Boston Scientific$37
- Siemens Medical Solutions USA, Inc.$33
- Cardiva Medical, Inc.$25
Across 17 payments — averaging $1945.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$18K
- EKOS Corporation$15K
What the payments were for
- Food & beverage$261100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GE HealthCare | 3 | $165 |
| Boston Scientific | 2 | $37 |
| Siemens Medical Solutions USA, Inc. | 1 | $33 |
| Cardiva Medical, Inc. | 1 | $25 |
How this compares
$261 in reported general payments places this provider in the 5th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 55 | $47,190 |
| XareltoRivaroxaban | 21 | $20,934 |
| ClopidogrelClopidogrel Bisulfate | 126 | $1,134 |
| Atorvastatin Calcium | 116 | $1,007 |
| Metoprolol Succinate | 97 | $783 |
| Rosuvastatin Calcium | 67 | $493 |
| Losartan Potassium | 41 | $438 |
| Cilostazol | 34 | $421 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 56 | $420 |
| Amlodipine Besylate | 25 | $302 |
| Lisinopril | 32 | $288 |
| Hydralazine Hcl | 14 | $253 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 13 | $253 |
| Carvedilol | 27 | $244 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $195 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Columbus
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- Michael JollyColumbus$281K
- Timothy SmithColumbus$149K
- Christopher HuffColumbus$119K
- Joseph CampbellColumbus$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.